Page 137 - Read Online

De Gaspari et al. Vessel Plus 2022;6:57 https://dx.doi.org/10.20517/2574-1209.2022.05 Page 11 of 13

23. Rapezzi C, Quarta CC, Riva L, et al. Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol
2010;7:398-408. DOI
24. Kittleson MM, Maurer MS, Ambardekar AV, et al. American Heart Association Heart Failure and Transplantation Committee of the
Council on Clinical Cardiology. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American
heart association. Circulation 2020;142:e7-e22. DOI PubMed
25. Murtagh B, Hammill SC, Gertz MA, Kyle RA, Tajik AJ, Grogan M. Electrocardiographic findings in primary systemic amyloidosis
and biopsy-proven cardiac involvement. Am J Cardiol 2005;95:535-7. DOI
26. Rapezzi C, Quarta CC, Guidalotti PL, et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid
scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur J Nucl Med Mol Imaging 2011;38:470-8. DOI
27. Quarta CC, Zheng J, Hutt D, et al. 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis. Eur Heart J
Cardiovasc Imaging 2021;22:1304-11. DOI PubMed PMC
28. Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working
Group on Myocardial and Pericardial Diseases. Eur Heart J 2021;42:1554-68. DOI PubMed PMC
29. Gameren II, Hazenberg BP, Bijzet J, van Rijswijk MH. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for
detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum 2006;54:2015-21. DOI
30. Fine NM, Arruda-Olson AM, Dispenzieri A, et al. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis.
Am J Cardiol 2014;113:1723-7. DOI PubMed
31. Quarta CC, Gonzalez-Lopez E, Gilbertson JA, et al. Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis. Eur
Heart J 2017;38:1905-8. DOI PubMed PMC
32. Picken MM, Herrera GA. Thioflavin T Stain: an easier and more sensitive method for amyloid detection. In: Picken MM, Herrera GA,
Dogan A, editors. Amyloid and Related Disorders. Cham: springer International Publishing; 2015. pp. 225-7. DOI
33. Pomerance A, Slavin G, McWatt J. Experience with the sodium sulphate-Alcian Blue stain for amyloid in cardiac pathology. J Clin
Pathol 1976;29:22-6. DOI
34. Castellani C, Fedrigo M, Frigo AC, et al. Application of confocal laser scanning microscopy for the diagnosis of amyloidosis.
Virchows Arch 2017;470:455-63. DOI PubMed
35. Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol 2015;24:343-50. DOI PubMed
36. Shen K, Sun W, Sun J, et al. [Classification of amyloidosis by laser micro-dissection and mass spectrometry based proteomic analysis].
Zhonghua Xue Ye Xue Za Zhi 2015;36:99-102. DOI PubMed PMC
37. Dasari S, Theis JD, Vrana JA, et al. Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses.
J Proteome Res 2014;13:2352-8. DOI
38. Buja L, Khoi NB, Roberts WC. Clinically significant cardiac amyloidosis. The American Journal of Cardiology 1970;26:394-405.
DOI
39. Roberts WC, Waller BF. Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. The American Journal of
Cardiology 1983;52:137-46. DOI
40. Smith TJ, Kyle RA, Lie J. Clinical Significance of Histopathologic Patterns of Cardiac Amyloidosis. Mayo Clin Proc 1984;59:547-55.
DOI
41. Leone O, Longhi S, Quarta CC, et al. New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis.
Amyloid 2012;19:99-105. DOI
42. Larsen BT, Mereuta OM, Dasari S, et al. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a
histological and proteomic analysis of 108 cases. Histopathology 2016;68:648-56. DOI PubMed
43. Porcari A, Bussani R, Merlo M, et al. Incidence and characterization of concealed cardiac amyloidosis among unselected elderly
patients undergoing post-mortem examination. Front Cardiovasc Med 2021;8:749523. DOI PubMed PMC
44. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the european society of
cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008;29:270-6. DOI PubMed
45. Eliot RS, Mcgee HJ, Blount SG. Cardiac Amyloidosis. Circulation 1961;23:613-22. DOI
46. Dinwoodey DL, Skinner M, Maron MS, Davidoff R, Ruberg FL. Light-chain amyloidosis with echocardiographic features of
hypertrophic cardiomyopathy. Am J Cardiol 2008;101:674-6. DOI PubMed
47. Philippakis AA, Falk RH. Cardiac amyloidosis mimicking hypertrophic cardiomyopathy with obstruction: treatment with
disopyramide. Circulation 2012;125:1821-4. DOI PubMed
48. Basso C, Michaud K, d'Amati G, et al. Association for European Cardiovascular Pathology. Cardiac hypertrophy at autopsy. Virchows
Arch 2021;479:79-94. DOI PubMed PMC
49. Feng D, Edwards WD, Oh JK, et al. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation
2007;116:2420-6. DOI PubMed
50. Neben-Wittich MA, Wittich CM, Mueller PS, Larson DR, Gertz MA, Edwards WD. Obstructive intramural coronary amyloidosis and
myocardial ischemia are common in primary amyloidosis. Am J Med 2005;118:1287. DOI PubMed
51. Pucci A, Aimo A, Musetti V, et al. Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with
extracellular volume in cardiac amyloidosis. J Am Heart Assoc 2021;10:e020358. DOI PubMed PMC
52. Frenzel H, Schwartzkopff B, Kuhn H, et al. Cardiac amyloid deposits in endomyocardial biopsies. Light microscopic, ultrastructural,
and immunohistochemical studies. Am J Clin Pathol 1986;85:674-80. DOI PubMed